INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $831,000 | -56.3% | 59,552 | -56.7% | 0.13% | -25.0% |
| Q2 2022 | $1,900,000 | -13.0% | 137,596 | +2.5% | 0.17% | -10.6% |
| Q1 2022 | $2,183,000 | +443.0% | 134,182 | +444.2% | 0.19% | +506.5% |
| Q4 2021 | $402,000 | -82.4% | 24,657 | -78.5% | 0.03% | -79.5% |
| Q2 2021 | $2,287,000 | -10.4% | 114,515 | +3.5% | 0.15% | -17.5% |
| Q1 2021 | $2,552,000 | -1.2% | 110,592 | +5.7% | 0.18% | +4.6% |
| Q4 2020 | $2,584,000 | -40.6% | 104,604 | -0.2% | 0.18% | -39.0% |
| Q3 2020 | $4,347,000 | -36.2% | 104,846 | +94.4% | 0.29% | +1.4% |
| Q3 2018 | $6,815,000 | +193.5% | 53,932 | +94.9% | 0.28% | +221.6% |
| Q2 2018 | $2,322,000 | -57.4% | 27,672 | +20.3% | 0.09% | -38.0% |
| Q3 2014 | $5,446,000 | – | 23,011 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |